Anderman Jonathan bought CMPX
April 29, 2026 · Form 4 insider transaction
Anderman Jonathan bought 25,000 shares of Compass Therapeutics, Inc. at $1.89 per share, a transaction worth $47.3K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,000
Price
$1.89
Total value
$47.3K
InsiderAnderman Jonathan
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateApril 29, 2026
Filing dateApril 29, 2026
Shares owned after196,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
150,000 of the shares represents unvested restricted stock units ("RSU") granted on January 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on January 2, 2027.